Zubsolv and Urticaria - a phase IV clinical study of FDA data
Summary:
Urticaria is reported as a side effect among people who take Zubsolv (buprenorphine hydrochloride; naloxone hydrochloride), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Suboxone, and have Drug dependence.
The phase IV clinical study analyzes which people have Urticaria when taking Zubsolv. It is created by eHealthMe based on reports of 1,003 people who have side effects when taking Zubsolv from the FDA, and is updated regularly.
What is Zubsolv?
Zubsolv has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 1,029 Zubsolv users. Check the latest studies of Zubsolv.
What is Urticaria?
Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,955 conditions by eHealthMe. Check the latest studies of Urticaria.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,003 people reported to have side effects when taking Zubsolv.
Among them, 16 people (1.6%) have Urticaria.

Among these 16 people:
How long have people been on Zubsolv when they have Urticaria? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Urticaria when taking Zubsolv? *
- female: 75 %
- male: 25 %
What is the age of people who have Urticaria when taking Zubsolv? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 46.15 %
- 30-39: 7.69 %
- 40-49: 30.77 %
- 50-59: 15.38 %
- 60+: 0.0 %
What are other drugs people take besides Zubsolv? *
- Suboxone: 4 people, 25.00%
- Trintellix: 1 person, 6.25%
What are other side effects people have besides Urticaria? *
- Itching: 7 people, 43.75%
- Rashes (redness): 4 people, 25.00%
- Peripheral Swelling: 3 people, 18.75%
- Weakness: 1 person, 6.25%
- Lacrimation Increased: 1 person, 6.25%
- Anger: 1 person, 6.25%
- Burning Sensation: 1 person, 6.25%
- Delusion (a false belief or opinion): 1 person, 6.25%
- Diarrhea: 1 person, 6.25%
- Drug Hypersensitivity: 1 person, 6.25%
What are the existing conditions these people have? *
- Drug Dependence: 4 people, 25.00%
- Pain: 2 people, 12.50%
- High Blood Pressure: 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Zubsolv and have Urticaria?
- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zubsolv:
- Zubsolv (1,029 reports)
Urticaria treatments and more:
- Urticaria (173,777 reports)
How severe was Urticaria and when was it recovered:
Expand to all the drugs that have ingredients of buprenorphine hydrochloride; naloxone hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zubsolv:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urticaria:
- Urticaria (2,612 drugs)
Browse all the conditions that are associated with Urticaria:
- Urticaria (2,955 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride (the active ingredients of Zubsolv) and Zubsolv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prednisone cause Retinal Artery Embolism? - now
- Athlete'S Foot and Abdominal Pain Upper - 10 seconds ago
- Asthma and Renal Artery Stenosis - 12 seconds ago
- Could Prevacid cause Angioedema? - 14 seconds ago
- Myorisan vs. Fish Oil, side effect and effectiveness comparison - 19 seconds ago
- Could Fluocinolone Acetonide cause Vertigo Aggravated? - 24 seconds ago
- Could Tolterodine cause Visual Acuity Reduced? - 27 seconds ago
- Could Carafate cause Nasal Dryness? - 29 seconds ago
- Could Cephalexin cause Multiple Myeloma? - 31 seconds ago
- Drug interactions of Adalat Cc and Heparin Sodium - 34 seconds ago